Avacta Group Plc (LON:AVCT – Get Free Report)’s share price shot up 13.2% during trading on Monday . The company traded as high as GBX 59.60 ($0.74) and last traded at GBX 58.93 ($0.74). 1,319,979 shares were traded during mid-day trading, an increase of 11% from the average session volume of 1,189,764 shares. The stock had previously closed at GBX 52.05 ($0.65).
Avacta Group Trading Down 3.8 %
The stock has a market cap of £193.12 million, a price-to-earnings ratio of -598.89 and a beta of 1.12. The business’s fifty day simple moving average is GBX 48.62 and its 200 day simple moving average is GBX 58.78. The company has a debt-to-equity ratio of 63.54, a current ratio of 1.29 and a quick ratio of 4.96.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Stories
- Five stocks we like better than Avacta Group
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Innovative Small-Cap Tech Stocks: Time to Buy, Sell, or Hold?
- What is a Low P/E Ratio and What Does it Tell Investors?
- Top 3 Stocks Goldman Sachs Predicts Will Dominate 2025
- Top Stocks Investing in 5G Technology
- Top 2 Auto Maintenance Stocks Gearing Up for 2025
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.